Skip to content
OpenCapital
Get started

Pacira BioSciences, Inc. PCRX Market capitalization

Market capitalization at other companies

Avanos Medical logo
Avanos MedicalAVNS
$651.57M-1.2%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$1.05B+9.5%
AtriCure logo
AtriCureATRC
$1.42B-9.9%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Enterprise value$1.21B+1.2%
P/E183.5×—
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%—
Net margin0.7%—
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%—
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Computed from the period-end share price: $915.07M.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s market capitalization?
Pacira BioSciences, Inc. (PCRX) reported market capitalization of $915.07M in Q1 2026.
How has Pacira BioSciences, Inc.'s market capitalization changed year-over-year?
Pacira BioSciences, Inc.'s market capitalization decreased by 20.4% year-over-year, from $1.15B to $915.07M.
What is the long-term trend for Pacira BioSciences, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s market capitalization has grown at a -16.0% compound annual growth rate (CAGR), from $2.67B to $1.11B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.